Digirad Corp. (NASDAQ:DRAD) has earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Analysts have set a 1-year consensus target price of $7.00 for the company and are expecting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Digirad Corp. an industry rank of 109 out of 265 based on the ratings given to related companies.
A number of equities research analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of Digirad Corp. from a “hold” rating to a “sell” rating in a report on Thursday, September 1st. B. Riley reaffirmed a “buy” rating and issued a $7.00 price target on shares of Digirad Corp. in a report on Tuesday, July 26th.
In other Digirad Corp. news, Director Jeffrey E. Eberwein purchased 5,625 shares of the stock in a transaction on Wednesday, September 14th. The shares were bought at an average cost of $5.00 per share, with a total value of $28,125.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey E. Eberwein purchased 28,482 shares of the stock in a transaction on Friday, August 19th. The stock was acquired at an average cost of $5.00 per share, for a total transaction of $142,410.00. Following the completion of the acquisition, the director now owns 12,500 shares of the company’s stock, valued at approximately $62,500. The disclosure for this purchase can be found here. 11.50% of the stock is currently owned by company insiders.
Several large investors have recently bought and sold shares of DRAD. JPMorgan Chase & Co. raised its stake in Digirad Corp. by 437.2% in the second quarter. JPMorgan Chase & Co. now owns 19,340 shares of the company’s stock valued at $100,000 after buying an additional 15,740 shares during the last quarter. O Shaughnessy Asset Management LLC raised its stake in Digirad Corp. by 289.4% in the second quarter. O Shaughnessy Asset Management LLC now owns 19,559 shares of the company’s stock valued at $101,000 after buying an additional 14,536 shares during the last quarter. AXA purchased a new stake in Digirad Corp. during the second quarter valued at about $194,000. Hillsdale Investment Management Inc. raised its stake in Digirad Corp. by 11.9% in the second quarter. Hillsdale Investment Management Inc. now owns 75,280 shares of the company’s stock valued at $388,000 after buying an additional 8,000 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Digirad Corp. by 13.3% in the second quarter. Bank of New York Mellon Corp now owns 81,374 shares of the company’s stock valued at $418,000 after buying an additional 9,568 shares during the last quarter. 60.63% of the stock is currently owned by institutional investors and hedge funds.
Shares of Digirad Corp. (NASDAQ:DRAD) traded up 2.65% during trading on Friday, reaching $5.03. The company had a trading volume of 23,709 shares. Digirad Corp. has a 1-year low of $3.95 and a 1-year high of $6.92. The stock has a market capitalization of $98.43 million, a price-to-earnings ratio of 3.08 and a beta of 1.37. The company’s 50 day moving average is $5.07 and its 200-day moving average is $5.26.
Digirad Corp. (NASDAQ:DRAD) last announced its quarterly earnings data on Thursday, July 28th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. Digirad Corp. had a net margin of 34.22% and a return on equity of 10.03%. On average, equities research analysts anticipate that Digirad Corp. will post $0.31 earnings per share for the current year.
Digirad Corp. Company Profile
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Digirad Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corp. and related companies with MarketBeat.com's FREE daily email newsletter.